scholarly journals Antibody Production in Response to Hepatitis B Surface Antigen in a Combination Hepatitis A/Hepatitis B Vaccine

2000 ◽  
Vol 182 (3) ◽  
pp. 1005-1005 ◽  
Author(s):  
Betsy Abraham ◽  
Dennis Parenti
1999 ◽  
Vol 180 (6) ◽  
pp. 2018-2022 ◽  
Author(s):  
Sharon Frey ◽  
Ron Dagan ◽  
Yaffa Ashur ◽  
Xiao Q. Chen ◽  
Jose Ibarra ◽  
...  

2015 ◽  
Vol 41 (08) ◽  
Author(s):  
E Reuss ◽  
N Evers ◽  
N Dietrich ◽  
J Vollmar ◽  
PM Schneider ◽  
...  

1986 ◽  
Vol 7 (7) ◽  
pp. 365-369 ◽  
Author(s):  
S.A Klotz ◽  
R. Normand ◽  
R. Silberman

AbstractA low rate of seroconversion to hepatitis B vaccine is reported. This occurred in healthy hospital employees from two separate institutions. A total of 236 individuals were evaluated in this study and only 53% or 124 persons developed protective levels of antibody to hepatitis B surface antigen following a complete vaccine series. In one hospital, 30% of the vaccine recipients developed antibody but not to a protective level. Employees who received the entire series in the arm or in the arm and buttock (mixed) had a significantly greater number of responders than employees who received the entire series in the buttock (P<.05). Recipients aged 50 to 59 years had a significantly lower response rate to the vaccine (P<.05). There was no correlation with the vaccinee's sex or the timing of the second injection. Vaccine was noted to have frozen in one hospital and accounted for some loss of antigenicity. This failure to respond to the vaccine has necessitated the use of booster injections of vaccine and continued antibody monitoring.


Vaccine ◽  
2008 ◽  
Vol 26 (48) ◽  
pp. 6064-6067 ◽  
Author(s):  
Yali Hu ◽  
Qiaozhen Wu ◽  
Biyun Xu ◽  
Zhenxian Zhou ◽  
Zhiqun Wang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document